Literature DB >> 20540149

Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome.

Tao Huang1, Subhachai Bhulaidok, Zhenzhen Cai, Tongcheng Xu, Fang Xu, Mark L Wahlqvist, Duo Li.   

Abstract

The relationship between n-3 PUFA and metabolic syndrome (MS) is not clear. The aim of this study was to examine relationships between plasma phospholipids (PL) n-3 PUFA and MS in Chinese subjects. Nine hundred and twenty-nine subjects were recruited in Hangzhou, China. Two hundred and ten (183 males, 27 females) with MS and 719 (545 males, 174 females) healthy subjects were identified in this cross-sectional study. The prevalence of MS in females (24.56%) was significantly higher than that in males (10.04%) in this population. Total PUFA (p<0.001), n-3 PUFA (p<0.001), and n-3:n-6 (p<0.001) were significantly lower in MS subjects compared to healthy subjects. Plasma phospholipid (PL), n-3 PUFA was significantly inversely associated with MS (p = 0.013). In addition, subjects with high levels of PL total fatty acids (FA) had a more than threefold higher likelihood of MS (OR = 3.44, 95% CI = 1.60-7.39) than the subjects with low levels of PL total FA. Our results suggest that plasma PL n-3 PUFA was significantly inversely associated with MS, while high total FA were positively associated with MS in Chinese.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540149     DOI: 10.1002/mnfr.201000025

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  15 in total

1.  Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women.

Authors:  Xiao-Wei Dai; Yu-Ming Chen; Fang-Fang Zeng; Li-Li Sun; Cao-Gang Chen; Yi-Xiang Su
Journal:  Eur J Nutr       Date:  2015-05-03       Impact factor: 5.614

2.  Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.

Authors:  Ju-Sheng Zheng; Amei Xu; Tao Huang; Xiaomei Yu; Duo Li
Journal:  Lipids       Date:  2012-04-19       Impact factor: 1.880

Review 3.  Promising therapies for treatment of nonalcoholic steatohepatitis.

Authors:  Mazen Noureddin; Alice Zhang; Rohit Loomba
Journal:  Expert Opin Emerg Drugs       Date:  2016-08-28       Impact factor: 4.191

Review 4.  Fatty acids and cardiometabolic health: a review of studies in Chinese populations.

Authors:  Liang Sun; Geng Zong; Huaixing Li; Xu Lin
Journal:  Eur J Clin Nutr       Date:  2020-08-14       Impact factor: 4.016

5.  Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects.

Authors:  Sebastiano Banni; Gianfranca Carta; Elisabetta Murru; Lina Cordeddu; Elena Giordano; Anna Rita Sirigu; Kjetil Berge; Hogne Vik; Kevin C Maki; Vincenzo Di Marzo; Mikko Griinari
Journal:  Nutr Metab (Lond)       Date:  2011-01-30       Impact factor: 4.169

Review 6.  Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis.

Authors:  Ju-Sheng Zheng; Tao Huang; Jing Yang; Yuan-Qing Fu; Duo Li
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

7.  Plasma phospholipid fatty acid composition and estimated desaturase activity in heart failure patients with metabolic syndrome.

Authors:  Seungmin Lee; Hyun Ju Do; Seok-Min Kang; Ji Hyung Chung; Eunju Park; Min-Jeong Shin
Journal:  J Clin Biochem Nutr       Date:  2012-07-06       Impact factor: 3.114

8.  Effect of polyunsaturated fatty acids on homocysteine metabolism through regulating the gene expressions involved in methionine metabolism.

Authors:  Tao Huang; Xiaojie Hu; Nicholas Khan; Jing Yang; Duo Li
Journal:  ScientificWorldJournal       Date:  2013-05-23

9.  Adipose tissue n-3 fatty acids and metabolic syndrome.

Authors:  E Cespedes; A Baylin; H Campos
Journal:  Eur J Clin Nutr       Date:  2014-08-06       Impact factor: 4.016

Review 10.  Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.

Authors:  J Assies; R J T Mocking; A Lok; H G Ruhé; F Pouwer; A H Schene
Journal:  Acta Psychiatr Scand       Date:  2014-03-21       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.